國立虎尾科技大學 |

Histone Mutations and Cancer

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Histone Mutations and Cancer/ edited by Dong Fang, Junhong Han.
其他作者:	Han, Junhong.
面頁冊數:	VII, 96 p. 17 illus., 15 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Protein Science. -
電子資源:	https://doi.org/10.1007/978-981-15-8104-5
ISBN:	9789811581045

Histone Mutations and Cancer
Histone Mutations and Cancer[electronic resource] /edited by Dong Fang, Junhong Han. - 1st ed. 2021. - VII, 96 p. 17 illus., 15 illus. in color.online resource. - Advances in Experimental Medicine and Biology,12832214-8019 ;. - Advances in Experimental Medicine and Biology,889.

Chapter 1: Overview of histone modification -- Chapter 2: The histone H3 family and its deposition pathways -- Chapter 3: Histone H3K27M Mutation in Brain Tumors -- Chapter 4: Histone Mutations and Bone Cancers -- Chapter 5: Histone H3G34 mutation in brain and bone tumors -- Chapter 6: Epigenetic-targeted treatments for H3K27M-mutant midline gliomas -- Chapter 7: Histone lysine to methionine mutation as anti-cancer drug target.

This book focuses on histone mutations, especially those mutations closely related to cancer. Genetic mutations and epigenetic alterations contribute to the development of a variety of cancers: recent genetic studies have identified e.g. H3K27M and H3G34R/V mutation in over 75% of DIPG cases, H3.3K36M mutation in more than 90% of chondroblastoma cases, and H3G34W/L mutation in over 90% of giant cell tumors of bone. Given the high incidence and tumorigenesis effects of histone H3 mutations, they are also referred to as oncohistones. This book highlights the advances made in the area over the past 10 years, and offers a state-of-the-art summary of epigenetic alternation, gene expression, protein structure, drug discovery, immunotherapy, and mouse modeling of histone H3 mutations in various tumors. Chiefly intended to provide researchers and graduate students with an overall picture of these mutations, it will also be of interest to researchers in basic oncology, clinical oncology, and epigenetics, as well as academics and clinical oncology practitioners.

ISBN: 9789811581045

Standard No.: 10.1007/978-981-15-8104-5doiSubjects--Topical Terms:

782127
Protein Science.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Histone Mutations and Cancer
LDR:02929nam a22004095i 4500 001 1047563
003 DE-He213
005 20210817062601.0
007 cr nn 008mamaa
008 220103s2021 si | s |||| 0|eng d
020 $a 9789811581045 $9 978-981-15-8104-5
024 7 $a 10.1007/978-981-15-8104-5 $2 doi
035 $a 978-981-15-8104-5
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Histone Mutations and Cancer $h [electronic resource] / $c edited by Dong Fang, Junhong Han.
250 $a 1st ed. 2021.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a VII, 96 p. 17 illus., 15 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Experimental Medicine and Biology, $x 2214-8019 ; $v 1283
505 0 $a Chapter 1: Overview of histone modification -- Chapter 2: The histone H3 family and its deposition pathways -- Chapter 3: Histone H3K27M Mutation in Brain Tumors -- Chapter 4: Histone Mutations and Bone Cancers -- Chapter 5: Histone H3G34 mutation in brain and bone tumors -- Chapter 6: Epigenetic-targeted treatments for H3K27M-mutant midline gliomas -- Chapter 7: Histone lysine to methionine mutation as anti-cancer drug target.
520 $a This book focuses on histone mutations, especially those mutations closely related to cancer. Genetic mutations and epigenetic alterations contribute to the development of a variety of cancers: recent genetic studies have identified e.g. H3K27M and H3G34R/V mutation in over 75% of DIPG cases, H3.3K36M mutation in more than 90% of chondroblastoma cases, and H3G34W/L mutation in over 90% of giant cell tumors of bone. Given the high incidence and tumorigenesis effects of histone H3 mutations, they are also referred to as oncohistones. This book highlights the advances made in the area over the past 10 years, and offers a state-of-the-art summary of epigenetic alternation, gene expression, protein structure, drug discovery, immunotherapy, and mouse modeling of histone H3 mutations in various tumors. Chiefly intended to provide researchers and graduate students with an overall picture of these mutations, it will also be of interest to researchers in basic oncology, clinical oncology, and epigenetics, as well as academics and clinical oncology practitioners.
650 2 4 $a Protein Science. $3 782127
650 2 4 $a Gene Expression. $3 582691
650 1 4 $a Cancer Research. $3 668358
650 0 $a Proteins . $3 1253493
650 0 $a Gene expression. $3 581931
650 0 $a Cancer research. $3 1253664
700 1 $a Han, Junhong. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1351291
700 1 $a Fang, Dong. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1351290
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811581038
776 0 8 $i Printed edition: $z 9789811581052
776 0 8 $i Printed edition: $z 9789811581069
830 0 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 889 $3 1253792
856 4 0 $u https://doi.org/10.1007/978-981-15-8104-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)